IFP Advisors, Inc - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 31 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$4,033
+4.4%
750
+100.0%
0.00%
Q1 2023$3,863
+96475.0%
3750.0%0.00%
Q4 2022$4
-99.9%
3750.0%0.00%
Q3 2022$4,0000.0%3750.0%0.00%
Q2 2022$4,000
-50.0%
375
-50.0%
0.00%
Q1 2022$8,000
+700.0%
750
+100.0%
0.00%
Q4 2021$1,0000.0%3750.0%0.00%
Q3 2021$1,0000.0%3750.0%0.00%
Q2 2021$1,0000.0%3750.0%0.00%
Q1 2021$1,000
-50.0%
3750.0%0.00%
Q4 2020$2,0000.0%3750.0%0.00%
Q3 2020$2,000
+100.0%
3750.0%0.00%
Q2 2020$1,000
-66.7%
375
-40.0%
0.00%
Q1 2020$3,0000.0%6250.0%0.00%
Q4 2019$3,000
-25.0%
6250.0%0.00%
Q3 2019$4,000
+100.0%
625
+66.7%
0.00%
Q4 2018$2,000
-50.0%
375
-40.0%
0.00%
Q3 2017$4,0000.0%6250.0%0.00%
Q2 2017$4,000
+33.3%
6250.0%0.00%
Q1 2017$3,000
+50.0%
625
+150.0%
0.00%
Q4 2016$2,0002500.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Penbrook Management LLC 344,060$1,634,0001.26%
Union Square Park Capital Management, LLC 400,000$1,900,0000.76%
P.A.W. CAPITAL CORP 100,000$475,0000.42%
PRECEPT MANAGEMENT LLC 150,000$713,0000.29%
Newbridge Financial Services Group, Inc. 73,500$349,0000.29%
SANDERS MORRIS HARRIS LLC 183,584$990,0000.22%
FRIESS ASSOCIATES LLC 555,000$2,636,0000.19%
PERRITT CAPITAL MANAGEMENT INC 30,651$146,0000.09%
Ikarian Capital, LLC 219,109$1,041,0000.05%
SEGALL BRYANT & HAMILL, LLC 705,823$3,352,0000.04%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders